Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents
It gives us great honour to welcome you to the 2017 Dalton Transactions themed issue: Frontiers in Radionuclide Imaging and Therapy, A chemical journey from naturally radioactive elements to targeted theranostic agents. This special issue recognises the contributions of Professor Isabel Santos from the Instituto Superior Técnico at the University of Lisbon, to the advancement of science in the field of radiopharmaceutical chemistry on the occasion of her recent retirement. Professor Santos has been working over the years on the coordination chemistry of f-elements, namely actinides (U(III/IV)) and lanthanides (e.g. Sm, Ho), as well as of d-transition metal compounds, mainly Re and 99m Tc. Some of those metal complexes featured interesting properties for applications in molecular imaging, targeted radionuclide therapy and theranostics. She has published more than 200 publications, and has been responsible for numerous research projects. Professor Santos has been the head of the Radiopharmaceutical Sciences Group for several years, and between 2013 -2015 she was the first President of the Centre for Nu lear " ien es and Te hnolog (C 2 TN) in Lisbon, a national research facility rated as E ellent the Portuguese Science Foundation. We would like to emphasise that Professor Santos not only made outstanding contributions to the inorganic chemistry community, but also pioneered in Portugal and Europe a move towards inclusion of women in science, where gender equality is currently a relevant concern in the academic environment worldwide. Indeed, she has been a role model for many of her female students and co-workers, not to mention her national and international collaborators. The recognized inter-/multi-disciplinary nature of the research domains proposed in this themed issue reflects Professor Santos´ varied scientific interests, which span basic research in inorganic/organometallic chemistry to more application oriented studies. Indeed, this issue provides a broad spectrum of studies and views on radiometal-based molecular complexes and nanoplatforms for molecular imaging, systemic radiotherapy and theranostics, with approximately 30 papers, authored by well-known experts in their field. There are articles focused on the production and radiochemistry of radiometals, such as those by Abrunhosa and co-workers (Fast and cost-effective cyclotron production of 61Cu using a natZn liquid target: an opportunity for radiopharmaceutical production and R&D) and Jurisson and coworkers (Chemistry 
III) Complexes as Radiotracers for Myocardial Perfusion Imaging and 99mTc-3Cboroxime: A Novel 99mTc(III) Complex [99mTcCl(CDO)(CDOH)2B-3C] (CDOH2 = Cyclohexanedione Dioxime; 3C-B(OH)2 = 3-(Carbamoylphenyl)boronic Acid) with High Heart Uptake and Long Myocardial Retention), cell-membrane transporters (Correia and coworkers, Technetium-99m complexes of L-arginine derivatives for targeting amino acid transporters) and thrombus (Caravan and co-workers, Fibrin-Targeting Probes for Thrombus Imaging) are also included in this issue. Moreover, imaging of inflammation and infection in vivo is also a subject of relevant interest as addressed by Kniess and co-workers (99mTechnetium-based Small Molecule Radiopharmaceuticals and Radiotracers Targeting Inflammation and Infection) and by Drlica and co-workers (Fluoroquinolones as imaging agents for bacterial infection)
in the corresponding Perspectives. Two Perspectives papers describe innovative methodologies towards the development of novel peptide-based molecular probes for targeting E-selectin (Iranzo and co-workers, A computational and experimental study to develop E-selectin targeted peptides for molecular imaging probes) and provide an overview on the use for metal complexes for multimodal imaging, which is currently considered a hot topic (Tóth and co-workers, Metal complexes for multimodal imaging of misfolded protein-related diseases). Apart from the molecular-based approaches, this special issue also comprises two full articles in which radiolabelled gold-based nanoparticles (AuNp) have been studied. For example, in the paper by Paulo and co-workers it has been demonstrated that thiolated bombesincontaining AuNp are potentially useful as target-specific GSH-mediated drug delivery systems (
I Vitro/I Vivo Peeli g of Multila ered A i o ar o late Gold Na oparti les Evide ed a Kinetically Stable 99mTc-label: Implications for Glutathione-mediated Drug Release). The work presented by Khoobchandani and co-workers (Mangiferin Functionalized Radioactive
Gold Nanoparticles Intraperitoneal Disease), which reviews the use of the α-emitting particles radionuclides for radioimmunotherapy. These contributions were organized and written to reach the broader audience of the inorganic chemistry/organometallic community interested in biomedical applications of radiometals.
Finally, we would like to thank the editorial staff at Dalton Transactions for making this themed issue possible. All the authors as well as reviewers are also acknowledged for their efforts and relevant contributions, and we hope this special issue will encourage further developments in this exciting research field. 
